NATALI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 21.060
AS - Asia 9.829
EU - Europa 8.201
SA - Sud America 1.772
Continente sconosciuto - Info sul continente non disponibili 612
AF - Africa 357
OC - Oceania 34
Totale 41.865
Nazione #
US - Stati Uniti d'America 20.364
SG - Singapore 3.094
CN - Cina 2.520
FI - Finlandia 2.143
HK - Hong Kong 1.805
IT - Italia 1.805
BR - Brasile 1.448
SE - Svezia 957
VN - Vietnam 914
BG - Bulgaria 674
DE - Germania 563
GB - Regno Unito 477
CA - Canada 435
FR - Francia 421
TR - Turchia 392
RU - Federazione Russa 327
UA - Ucraina 237
JP - Giappone 163
IN - India 162
KR - Corea 159
SM - San Marino 139
BD - Bangladesh 123
AR - Argentina 119
IE - Irlanda 95
IQ - Iraq 88
MX - Messico 85
CH - Svizzera 79
CI - Costa d'Avorio 75
ZA - Sudafrica 52
EC - Ecuador 51
ID - Indonesia 51
AT - Austria 50
UZ - Uzbekistan 49
SN - Senegal 47
PK - Pakistan 46
ES - Italia 43
SA - Arabia Saudita 43
CO - Colombia 41
VE - Venezuela 41
KE - Kenya 40
JM - Giamaica 38
MA - Marocco 38
NL - Olanda 37
PL - Polonia 36
AU - Australia 28
CR - Costa Rica 27
BE - Belgio 26
CL - Cile 24
PY - Paraguay 23
AE - Emirati Arabi Uniti 22
NG - Nigeria 21
EG - Egitto 20
TT - Trinidad e Tobago 19
JO - Giordania 18
TN - Tunisia 18
CZ - Repubblica Ceca 17
HN - Honduras 17
NP - Nepal 17
TW - Taiwan 17
PH - Filippine 16
IR - Iran 14
DZ - Algeria 13
MY - Malesia 13
AL - Albania 12
IL - Israele 12
NI - Nicaragua 12
PT - Portogallo 12
DO - Repubblica Dominicana 11
LB - Libano 11
SV - El Salvador 11
PE - Perù 10
PS - Palestinian Territory 10
UY - Uruguay 10
AZ - Azerbaigian 9
GT - Guatemala 9
KZ - Kazakistan 9
PR - Porto Rico 9
LT - Lituania 8
OM - Oman 8
PA - Panama 7
BB - Barbados 6
GR - Grecia 6
MN - Mongolia 6
RO - Romania 6
TH - Thailandia 6
BJ - Benin 5
BO - Bolivia 5
ET - Etiopia 5
NZ - Nuova Zelanda 5
RS - Serbia 5
AM - Armenia 4
DK - Danimarca 4
GE - Georgia 4
KW - Kuwait 4
BH - Bahrain 3
EE - Estonia 3
EU - Europa 3
HU - Ungheria 3
KG - Kirghizistan 3
LK - Sri Lanka 3
Totale 41.195
Città #
Ashburn 2.308
Helsinki 1.906
Singapore 1.790
Hong Kong 1.787
Fairfield 1.657
Woodbridge 1.363
San Jose 1.172
Houston 1.026
Santa Clara 1.002
Ann Arbor 904
Chandler 846
Dallas 729
Sofia 671
Seattle 659
Shanghai 631
Wilmington 553
Council Bluffs 550
Beijing 536
Milan 532
Cambridge 528
New York 463
Princeton 327
Boardman 326
Los Angeles 282
Jacksonville 276
Ottawa 275
Lawrence 260
Izmir 246
Medford 240
Ho Chi Minh City 225
Lauterbourg 215
Hefei 191
Serra 187
Nanjing 164
Seoul 154
Tokyo 144
Hanoi 140
São Paulo 121
Buffalo 118
Des Moines 114
London 109
Pisa 109
Florence 107
Istanbul 104
Paris 103
Redondo Beach 103
San Diego 95
Dearborn 81
Dong Ket 80
Nanchang 78
Abidjan 75
Frankfurt am Main 71
Bern 70
Lancaster 70
Chicago 67
Munich 65
San Francisco 55
Rome 48
Dakar 47
Rio de Janeiro 47
The Dalles 42
Falls Church 41
Kunming 41
Ogden 41
Toronto 41
Changsha 40
Redwood City 40
Jüchen 39
Tashkent 39
Washington 39
Nuremberg 37
Brasília 36
Nairobi 36
Phoenix 36
Shenyang 36
Atlanta 35
Brooklyn 35
Columbus 35
Da Nang 35
Hebei 35
Baghdad 34
Lucca 33
Tianjin 33
Turku 33
Haiphong 32
Belo Horizonte 31
Dhaka 31
Curitiba 30
Vienna 30
Warsaw 30
Jiaxing 27
Johannesburg 27
Montreal 27
Orem 27
Fuzhou 26
Hangzhou 26
Norwalk 26
Düsseldorf 25
Boulder 24
Orange 23
Totale 28.536
Nome #
ANF IN PRIMARY ALDOSTERONISM - EFFECT OF DIETARY NA+ AND POSTURAL CHANGES AND RELATIONSHIP WITH ALDOSTERONE 2.050
Prognostic Value Of 24-hour Ambulatory Blood Pressure And Heart Rate Patterns In Diabetes: A 20-year Longitudinal Analysis Of The Chronic Diabetes Complications And All-cause Mortality In Pisa From 1999 Onwards (CHAMP1ON) Study Cohort 509
Hypertension: a metabolic disorder? 287
Modulation of postprandial glycemic responses by noncarbohydrate nutrients provides novel approaches to the prevention and treatment of type 2 diabetes 259
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance 256
Noninvasive measurement of forearm blood flow and oxygen consumption by near-infrared spectroscopy 233
Insulin resistance and hyperinsulinemia - No independent relation to left ventricular mass in humans 230
Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial. 223
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans - A quantitative study 220
Insulin resistance, adipose depots and gut: Interactions and pathological implications 218
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes 211
Diabetes and high blood pressure 209
alpha-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population 209
Dietary sodium change in primary aldosteronism. Atrial natriuretic factor, hormonal, and vascular responses. Hypertension. 201
Effects of insulin on the kidney and the cardiovascular system 201
Insulin: new roles for an ancient hormone 197
Alterations in adipose tissue distribution, cell morphology and function mark primary insulin hypersecretion in youths with obesity 192
Independent stimulation of glucose metabolism and Na+-K+ exchange by insulin in the human forearm. 192
Effect of insulin on skeletal muscle metabolism in essential hypertension 191
Beta-cell function is associated with carotid intima-media thickness independently of insulin resistance in healthy individuals 189
The novel collagen matrikine, endotrophin, is associated with mortality and cardiovascular events in patients with atherosclerosis 187
Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach 185
Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene 185
Beta-cell function in obesity: effects of weight loss 184
At any Level of Adiposity, Relatively Elevated Leptin Concentrations Are Associated With Decreased Insulin Sensitivity 183
Hypertension, insulin resistance, and diabetes 182
Effects of short and prolonged mild intracellular nitric oxide manipulations on various aspects of insulin secretion in INS-1E β-cells. 181
Acute insulin administration does not affect plasma leptin levels in lean or obese subjects 180
Euglycemic clamp insulin sensitivity and longitudinal systolic blood pressure: role of sex 180
Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data 180
Persistent congestion, renal dysfunction and inflammatory cytokines in acute heart failure: a prognosis study 180
Effect of acute hyperglycemia on insulin secretion in humans 177
Hyperinsulinemia and autonomic nervous system dysfunction in obesity - Effects of weight loss 177
Early metabolic markers of the development of dysglycaemia and type 2 diabetes and their physiological significance 177
Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case–control study 177
Gamma-glutamyltransferase, arterial remodeling and prehypertension in a healthy population at low cardiometabolic risk 175
Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies 172
Insulino Resistenza e Flusso Ematico: Studi con L'Adenosina in Pazienti con Ipertensione Essenziale 171
Assessment of insulin-glucose uptake dose-response characteristics in the non-steady state 171
Endothelial dysfunction in type 2 diabetes 171
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database 171
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension 170
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM 170
Use of Vascular Assessments and Novel Biomarkers to Predict Cardiovascular Events in Type 2 Diabetes: The SUMMIT VIP Study 170
Intestinal glucose absorption is a key determinant of 1-hour postload plasma glucose levels in nondiabetic subjects 169
Effect of insulin on skeletal muscle metabolism in essential hypertension 168
Relation of large artery remodelling and distensibility to insulin-resistance in patients with type 2 diabetes 168
Determinants of postabsorptive endogenous glucose output in non-diabetic subjects 168
Cardiovascular organ damage in type 2 diabetes mellitus: The role of lipids and inflammation 168
Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance. The GISIR database. 166
Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: A European cross-sectional study 166
OBEDIS Core Variables Project: European Expert Guidelines on a Minimal Core Set of Variables to Include in Randomized, Controlled Clinical Trials of Obesity Interventions 166
Influence of duration of obesity on the insulin resistance of obese non-diabetic patients 164
Body Weight, Not Insulin Sensitivity or Secretion, May Predict Spontaneous Weight Changes in Nondiabetic and Prediabetic Subjects The RISC Study 164
Glucose uptake saturation explains glucose kinetics profiles measured by different tests 164
Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function” 164
Cardiac Reserve and Exercise Capacity: Insights from Combined Cardiopulmonary and Exercise Echocardiography Stress Testing 162
Family history of diabetes predisposes to cardiovascular disease among patients with type 2 diabetes: What is the nature of the association? 161
Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance 160
A novel fasting blood test for insulin resistance and prediabetes 160
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study 157
Insulin sensitivity and fasting insulin: association with indicators of cardiovascular disease in healthy subjects. The RISC Study 156
A mixed nutrient preload attenuates glucose-induced endothelial dysfunction in individuals with abnormal glucose tolerance 156
Measurement of insulin-mediated glucose uptake: Direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp 155
Effects of angiotensin-converting enzyme inhibition on carbohydrate metabolism and insulin sensitivity in hypertensive patients 153
Coronary artery disease and stroke in type 2 diabetic patients: possible role of a raised central pulse pressure 153
Reciprocal association between insulin sensitivity and the haematocrit in man 153
Impaired insulin action on skeletal muscle metabolism in essential hypertension 152
Influence of endogenous NEFA on beta cell function in humans 152
Carotid artery remodeling and compliance, insulin resistance, and lipid metabolism in type 2 diabetic patients. 151
Insulin-resistance and triglycerides as independent predictors of the early macrovascular involvement in type 2 diabetic patients 151
Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality 151
Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes 149
A short-term increase in dietary cholesterol and fat intake affects high-density lipoprotein composition in healthy subjects 149
Autonomic and hemodynamic responses to insulin in lean and obese humans 148
Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. 148
Insulin resistance, insulin response, and obesity as indicators of metabolic risk 148
Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications 146
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy RID F-2315-2010 146
The effect of lipoproteins on endothelial nitric oxide synthase is modulated by lipoperoxides 146
Value of combined cardiopulmonary and echocardiography stress test to characterize the haemodynamic and metabolic responses of patients with heart failure and mid-range ejection fraction 146
Critical evaluation of the questionnaires assessing adherence to the Mediterranean diet that are based on servings 146
Coronary atherosclerosis in non-insulin-dependent diabetes (NIDDM): Risk factors (RF) and impact on mortality. 145
Association of fasting glucagon and proinsulin concentrations with insulin resistance 144
Effects of Mild Acute Hypertriglyceridemia on Fasting and Post-Load Glucose Homeostasis 143
Influence of apolipoproteins on the association between lipids and insulin sensitivity: a cross-sectional analysis of the RISC Study 142
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis 142
Muscle metabolism and exercise tolerance in subclinical hypothyroidism: A controlled trial of levothyroxine 141
HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease. 141
Effect of a reduced-fat diet with or without pravastatin on glucose tolerance and insulin sensitivity in patients with primary hypercholesterolemia 140
Insulin resistance of stress: Sites and mechanisms 140
A genome-wide association study of IVGTT-based measures of first-phase insulin secretion refines the underlying physiology of type 2 diabetes variants 140
Early time-restricted carbohydrate consumption vs conventional dieting in type 2 diabetes: a randomised controlled trial 139
Circadian heart rate fluctuations predict cardiovascular and all-cause mortality in type 2 and type 1 diabetes: a 21-year retrospective longitudinal study 139
Renovascular hypertension and insulin sensitivity 139
Increased gluconeogenesis in type 2 diabetes: Substrate contribution and modulation by lipolysis. 139
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 139
Triglyceride-rich very low-density lipoproteins (VLDL) are independently associated with insulin secretion in a multiethnic cohort of adolescents 139
Glomerular Hyperfiltration Predicts Kidney Function Decline and Mortality in Type 1 and Type 2 Diabetes: A 21-Year Longitudinal Study 138
Statins, LDL Cholesterol Control, Cardiovascular Disease Prevention, and Atherosclerosis Progression: A Clinical Perspective 138
Totale 19.211
Categoria #
all - tutte 124.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.443


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.587 0 0 0 224 534 392 63 171 132 52 150 869
2022/20232.759 400 317 178 201 303 359 23 219 482 32 208 37
2023/20242.458 270 273 334 182 375 421 82 71 46 42 85 277
2024/20258.028 52 331 76 326 635 952 610 484 913 1.107 831 1.711
2025/202611.135 731 1.195 1.075 958 860 906 1.133 472 2.362 832 349 262
2026/20273.549 366 943 1.887 353 0 0 0 0 0 0 0 0
Totale 41.865